Research graph
References from Absence of Fibrosis Influences Prognosis of Cardiac Resynchronization in Nonischemic Cardiomyopathy. Local targets link to admitted publications; unresolved targets remain external evidence.
An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
2023 · External reference
2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy
10.1093/eurheartj/ehab364 · 2021 · External reference
2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
10.1093/eurheartj/ehac262 · 2022 · External reference
Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis
10.1016/j.jchf.2016.09.017 · 2017 · External reference
Improved risk stratification for ventricular arrhythmias and sudden death in patients with nonischemic dilated cardiomyopathy
10.1016/j.jacc.2021.04.030 · 2021 · External reference
Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in patients with cardiac resynchronization therapy: the GAUDI-CRT study
10.1016/j.jcmg.2017.04.021 · 2018 · External reference
Relationship of LVEF and myocardial scar to long-term mortality risk and mode of death in patients with nonischemic cardiomyopathy
10.1161/circulationaha.120.048477 · 2021 · External reference
Late gadolinium enhancement Magnetic Resonance Imaging (MRI) for predicting left ventricular reverse remodeling in non-ischemic cardiomyopathy: a systematic review and meta-analysis
10.3390/jcm14030895 · 2025 · External reference
Cardiac MRI-derived myocardial fibrosis and ventricular dyssynchrony predict response to cardiac resynchronization therapy in patients with nonischemic dilated cardiomyopathy
10.1148/ryct.220127 · 2023 · External reference
Late gadolinium enhancement and outcome of cardiac resynchronization therapy in non-ischemic cardiomyopathy
10.1016/j.ijcard.2024.132618 · 2025 · External reference
MAgnetic resonance imaging based DUal lead cardiac Resynchronization therapy: A prospectIve Left Bundle Branch Pacing study (MADURAI LBBP study)
10.1016/j.hrthm.2023.05.019 · 2023 · External reference
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
2021 · External reference
Unresolved reference
2013 · External reference
Cardiac magnetic resonance-derived myocardial scar is associated with echocardiographic response and clinical prognosis of left bundle branch area pacing for cardiac resynchronization therapy
10.1093/europace/euad326 · 2023 · External reference
Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy
10.1016/j.jacc.2012.05.054 · 2012 · External reference
Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
10.1016/j.jacc.2017.07.712 · 2017 · External reference
Cardiac magnetic resonance identifies responders to cardiac resynchronization therapy with an assessment of septal scar and left ventricular dyssynchrony
10.3390/jcm12227182 · 2023 · External reference
Left ventricular regional glucose metabolism in combination with septal scar extent identifies CRT responders
10.1007/s00259-020-05161-7 · 2021 · External reference
Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation
10.1016/j.jacc.2021.11.050 · 2022 · External reference
CMR feature tracking–based left atrial mechanics predicts response to cardiac resynchronization therapy and adverse outcomes
10.1016/j.hrthm.2024.03.028 · 2024 · External reference
Mechanical dyssynchrony combined with septal scarring reliably identifies responders to cardiac resynchronization therapy
10.3390/jcm12186108 · 2023 · External reference
Galectin-3 predicts response and outcomes after cardiac resynchronization therapy
10.1186/s12967-018-1675-4 · 2018 · External reference
Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy
10.1093/europace/eus104 · 2012 · External reference
Ventricular arrhythmia risk is associated with myocardial scar but not with response to cardiac resynchronization therapy
10.1093/europace/euaa142 · 2020 · External reference
Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy
10.1093/europace/euac157 · 2023 · External reference
10.1093/eurheartj/ehs104
10.1093/eurheartj/ehs104 · 2012 · External reference
The role of cardiac magnetic resonance to predict response to cardiac resynchronization therapy: a systematic review and meta-analysis
10.19102/icrm.2024.15111 · 2024 · External reference
Unresolved reference
2024 · External reference
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
10.1056/nejmoa032423 · 2004 · External reference
The addition of a defibrillator to resynchronization therapy decreases mortality in patients with nonischemic cardiomyopathy
10.1016/j.jchf.2021.02.013 · 2021 · External reference
Declining risk of sudden death in heart failure
10.1056/nejmoa1609758 · 2017 · External reference
Defibrillator implantation in patients with nonischemic systolic heart failure
10.1056/nejmoa1608029 · 2016 · External reference
Implantable cardioverter defibrillator in patients with nonischemic systolic heart failure with and without cardiac resynchronization therapy: extended Follow-up study of the DANISH trial
10.1161/circulationaha.123.065560 · 2023 · External reference
Risk stratification in nonischemic dilated cardiomyopathy using CMR imaging: a systematic review and meta-analysis
10.1001/jama.2024.13946 · 2024 · External reference
Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis
10.1016/j.jcmg.2016.01.033 · 2016 · External reference
10.1161/circulationaha.114.011283
10.1161/circulationaha.114.011283 · 2014 · External reference
2023 ESC guidelines for the management of cardiomyopathies
10.1093/eurheartj/ehad194 · 2023 · External reference
Device runtime and costs of cardiac resynchronization therapy pacemakers - a health claims data analysis
2022 · External reference
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: a state-of-the-art review
10.1016/j.hrthm.2024.05.057 · 2025 · External reference
